市场风云突变! 谁能稳坐“减肥药王”宝座?

Ofweek光电信息网
26 Feb

“一家独大”终结。《投资者网》蔡俊风生水起的减肥药,一度让诺和诺德超越LV成为欧洲市值最大的上市公司。如今,市场悄然发生变化。近期,诺和诺德公开一起并购诉讼,被告一方为华人科学家及其企业。同时,礼来的减肥药在国内开售,区域性的销售法规出台。司美格鲁肽在华“一家独大”的局面被终结,一股新的竞争浪潮正在袭来。一波未平一波又起故事的起源点,始于几年前的一笔交易。2023年,诺和诺德以最高13亿美元收购...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10